Background: Volume-outcome relationships in pancreatic surgery are well established, but an optimal
Introduction
Pancreatic carcinoma affects 10 per 100,000 persons annually. 1 Resection offers the only chance for cure in patients with pancreatic or periampullary (duodenum, ampulla, distal bile duct) carcinoma. Pancreatic surgery is traditionally regarded as low-volume, high-complex surgery. Many studies have clearly demonstrated improved postoperative outcomes following pancreatoduodenectomy (PD) in centers with higher procedural volumes compared to low volume hospitals. However, most studies examine volume-outcome relationships up to more than 20 procedures per year, and an optimal volume cut-off level is currently unknown. [2] [3] [4] [5] Over the past decade, centralization of pancreatic surgery has occurred in The Netherlands which was accompanied by improved postoperative and long-term survival. [6] [7] [8] [9] Nationwide minimum volumes have been set for various procedures and are reviewed periodically. For PD, in 2011 the Dutch Society for Surgery has set a minimum volume level of 20 procedures per center annually. 10 The question was raised whether further increasing the volume cut-off for PD from 20 to 40 could further improve outcomes. The aim of this study was to examine postoperative mortality and long-term survival in patients who underwent PD for primary pancreatic or periampullary malignancy in The Netherlands with hospital volume categories higher than previously examined.
Methods

Patient selection
This study was approved by the review board of the Netherlands Comprehensive Cancer Organization (IKNL), which was established to protect the privacy rights of patients and hospitals in the Netherlands Cancer Registry (NCR). Newly diagnosed malignancies in The Netherlands are registered in the populationbased NCR, covering 17 million inhabitants. Completeness is estimated to be at least 95%. Topography and morphology are coded according to the international Classification of Diseases for Oncology (ICD-O). 11 The tumor -lymph node -metastasis (TNM) classification was used to record tumor stage at diagnosis. 12 Survival data was obtained from the Municipal Personal Records Database.
All patients who underwent a PD (either pylorus-preserving or Whipple-Kausch) for primary pancreatic (C25), ampulla of Vater (C24.1), extrahepatic bile duct (C24.0) or duodenal (C17.0) adenocarcinoma between 2005 and 2013 were selected from the NCR. Patients residing or resected abroad, other (pancreatic) resections and age under 18 years old were excluded. Tumor location was categorized as pancreas or periampullary (ampulla, distal bile duct and duodenum). Tumor stage (TNM 6th (2005 (TNM 6th ( -2009 ) and 7th (2010-2013) edition) was based on pathological TNM. Socioeconomic status (SES) was based on The Netherlands Institute for Social Research and deciles were collapsed into three categories (high: 1st-3rd, intermediate: 4th-7th, low: 8th-10th deciles).
Hospital volume and outcome measures
Hospital volume was categorized as <5, 5-19, 20-39 and 40 PDs per year. The highest volume category was based on doubling of the current volume cut-off of 20 PDs per year. 6, 9 Hospital volume classification was based on the number of PDs for primary malignancies. The volume category per hospital was calculated for each years separately. For each hospital, the volume category could vary per year. To account for late fatal outcomes of postoperative complications, postoperative mortality was defined as death from any cause within 90 days postoperatively. Patients with metastatic disease undergoing PD (n = 61) were excluded from the analysis of survival. Overall survival (OS) was defined as the time between PD and death. Patients alive after December 31st, 2014 were censored. To minimize the influence of postoperative mortality on results of long-term survival, patients alive at 90 days postoperatively were included in the analysis of conditional survival (CS).
Statistical analysis
Baseline patient characteristics (gender, age, prior cancer, SES), tumor characteristics (location, stage, grade) and treatment characteristics (margin status, lymph nodes, chemotherapy) were compared between hospital volume categories using Pearson's chi-square tests. A p-value <0.05 was considered statistically significant. The chi-square test was used to investigate the association between hospital volume and postoperative outcomes. Univariable and multivariable logistic regression analyses were performed to investigate hospital volume and the influence of patient and tumor characteristics on 90-day postoperative mortality. Supplementary multilevel analysis did not reveal relevant clustering within hospitals (likelihood ratio test, p = 0.14) and was discarded. Cox proportional hazard regression analysis was used to evaluate the relation between hospital volume and (conditional) survival. Characteristics with a p < 0.10 in univariable analysis were entered into multivariable models, as well as period of surgery to adjust for possible time effects of (high) hospital volumes. Hospital volume was entered in all models. Analyses were performed using STATA/SE (version 13.0; STATA Corp., College Station, Texas, USA). 
Results
Patient and hospital characteristics
Discussion
In this nationwide population-based study including over 3400 PDs for primary pancreatic and periampullary carcinoma, an improved postoperative mortality, increased use of adjuvant chemotherapy and higher number of retrieved lymph nodes was observed in centers performing >40 PDs/year, compared to each lower volume category. Significantly favorable OS and CS were found in centers performing 20 or more procedures annually. These results were not confounded by time periods of surgery.
Our findings regarding 90-day mortality are consistent with a recent study using the National Cancer Data Base, in which the unadjusted 90-day mortality rate for PD was 7.4%. Similarly, also in our study 90-day mortality was significantly lower in each higher hospital volume category, up to a category of more than 40 procedures annually. 5 The US study did not report survival outcomes. To our knowledge, this study is the first to examine long-term (survival) volume-outcome relationships including hospitals performing >40 PDs annually. A long-term volumeoutcome effect may reflect better quality of surgery (e.g. high percentage R0 resection is associated with lower local recurrence rate), but also better management of late-follow up events (e.g., late postoperative morbidity, disease progression). Conditional survival reflects the probability of surviving an additional period of time, based on a specific length of time already survived. For patients with pancreatic carcinoma it was previously demonstrated that CS is a better estimator of survival compared to traditional survival estimates. 13 In our study, CS reflects the survival of patients following the initial short-term mortality zone of 90 days and was significantly improved in both volume categories beyond 20 procedures per year compared to lower hospital volumes, and no statistically significant difference was found in volume categories beyond 40 procedures per year compared to a 20-39 hospital volume category. As such, in the present study improved long-term outcomes required a lower threshold than improved short-term outcomes. Long-term outcomes are influenced by more factors than just short-term postoperative complications. Many patients undergoing surgery in high volume hospitals will receive both adjuvant therapy and management of follow-up events in their referring hospitals. Therefore, to provide high-quality care pathways to all patients, centralization of surgical treatment should be accompanied by close collaboration between pancreatic (surgery) centers and referring hospitals. Patient (SES), tumor and prognostic treatment characteristics differed between hospital volume categories. Although higher volume hospitals resected less patients with TNM Stage I disease, patient SES was higher. Possibly, patients with a higher SES prefer surgery in higher volume, mainly academic centers. Furthermore, with increasing hospital volume, more favorable margin status (R0), number of examined lymph nodes and use of adjuvant chemotherapy were found. More experience with the disease in higher volumes centers might be associated with this finding.
14 However, differences between hospital volumes regarding these important prognostic treatment features did not explain the hospital volume effect in long-term survival. Increasing capabilities to support patients with postoperative complications may delay some postoperative mortality beyond the 30-day period. 15, 16 Hospitals may differ in their capability to timely recognize and adequately manage severe complications after pancreatic surgery ('failure-to-rescue'). 17 In a previous study, doubled mortality rates at 90-compared to 30-postoperative days following resection for pancreatic carcinoma were found in all hospital volume categories. 5 In our study, the most favorable 90-day mortality was found in >40 PDs/year centers. There was non-significant improvement in mortality during the study period. However, as was previously demonstrated, during the study period there was an increase in the number of T3 and N1 patients being resected and an increasing age of resected patients. 9, 18 Especially elderly patients were at increased risk of postoperative mortality.
Due to an almost doubling of pancreatic resections in the Netherlands within eight years, hospital volumes in our study automatically increased over time ('volume creep'). 19 However, a further decrease in the number of hospitals performing pancreatic surgery in most recent years indicates an ongoing centralization of pancreatic surgery in the Netherlands. 4, 6, 9 Based on the current data a volume-plateau for 90-day mortality and overall survival cannot yet be determined. Furthermore, learning curves of hospitals with still increasing volumes could influence outcomes. This study has some limitations mainly related to the available data in the NCR-database. First, no comorbidity data were available. Negative impacts of comorbid conditions on outcomes following pancreatic surgery have been described and may differ between hospital volume categories. 16, 20, 21 Second, a hospital volume classification based on the number of PDs for primary malignancies was used while the actual volume standard in the Netherlands is based on PD for benign and malignant diagnoses. Therefore, volume categories of hospitals might be slightly underestimated. However, the vast majority of PDs are performed for pancreatic malignancy. 7 With ongoing centralization, future registry studies can investigate the association between outcomes of PD and hospital volumes at still higher cutoffs. Based on the current data we cannot determine whether the plateau for 90-day mortality and overall survival has been reached with 40 PDs annually. Concluding, the volume-outcome relationship for PD persists also in centers who perform 40 procedures annually, both for lower 90-day mortality rate and overall survival, as compared to lower volume categories. The volume plateau for pancreatic surgery has yet to be determined. Ultimately, research should extend beyond solely hospital volume numbers. Including adequate case-mix correction, surgeon volume, completeness of multidisciplinary care, traveling distances, patient preferences, and other factors all contribute to a more nuanced but complex discussion regarding the volume-outcome relationship in pancreatic surgery.
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